Re: Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma

被引:0
|
作者
Flanigan, Robert C. [1 ]
机构
[1] Loyola Univ, Med Ctr, Stritch Sch Med, Dept Urol, 2160 1st Ave, Maywood, IL 60153 USA
关键词
D O I
10.1016/j.eururo.2019.02.018
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:876 / 877
页数:3
相关论文
共 50 条
  • [1] Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma
    Staehler, Michael
    Battle, Dena
    Bex, Axel
    Hammers, Hans
    George, Daniel
    EUROPEAN UROLOGY, 2018, 74 (06) : 842 - 843
  • [2] Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
    Mejean, A.
    Ravaud, A.
    Thezenas, S.
    Colas, S.
    Beauval, J. -B.
    Bensalah, K.
    Geoffrois, L.
    Thiery-Vuillemin, A.
    Cormier, L.
    Lang, H.
    Guy, L.
    Gravis, G.
    Rolland, F.
    Linassier, C.
    Lechevallier, E.
    Beisland, C.
    Aitchison, M.
    Oudard, S.
    Patard, J. -J.
    Theodore, C.
    Chevreau, C.
    Laguerre, B.
    Hubert, J.
    Gross-Goupil, M.
    Bernhard, J. -C.
    Albiges, L.
    Timsit, M. -O.
    Lebret, T.
    Escudier, B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (05): : 417 - 427
  • [3] Has the Age of Cytoreductive Nephrectomy Come to an End? Commentary on: Sunitinib Alone or After Nephrectomy in Metastatic Renal-Cell Carcinoma
    Kesch, Claudia
    Black, Peter C.
    UROLOGY, 2018, 121 : 1 - 2
  • [4] TESTING THE EXTERNAL VALIDITY OF CARMENA TRIAL COMPARING SUNITINIB ALONE OR AFTER NEPHRECTOMY IN METASTATIC RENAL-CELL CARCINOMA
    Arora, Sohrab
    Sood, Akshay
    Dalela, Deepansh
    Patel, Amit
    Keeley, Jacob
    Fotouhi, Audrey
    Rakic, Nikola
    Prokopiv, Ulyana
    Quoc-Dien Trinh
    Rogers, Craig G.
    Menon, Mani
    Abdollah, Firas
    JOURNAL OF UROLOGY, 2019, 201 (04): : E70 - E70
  • [5] Metastatic Renal Cell Carcinoma: Nephrectomy plus Sunitinib versus Sunitinib Alone
    Kroeger, Nils
    Bedke, Jens
    Burchardt, Martin
    AKTUELLE UROLOGIE, 2019, 50 (02) : 132 - 134
  • [6] Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma after Nephrectomy
    Klatte, Tobias
    EUROPEAN UROLOGY, 2017, 71 (05) : 835 - 836
  • [7] Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy
    Salmasi, Amirali
    Faiena, Izak
    Drakaki, Alexandra
    Pantuck, Allan J.
    EUROPEAN UROLOGY, 2018, 74 (01) : 119 - 121
  • [8] Re: Pazopanib Versus Sunitinib in Metastatic Renal-cell Carcinoma
    Sun, Maxine
    Quoc-Dien Trinh
    Perrotte, Paul
    Karakiewicz, Pierre I.
    EUROPEAN UROLOGY, 2014, 65 (05) : 1014 - 1015
  • [9] Re: Pazopanib Versus Sunitinib in Metastatic Renal-cell Carcinoma
    Ouzaid, Idir
    Rini, Brian
    EUROPEAN UROLOGY, 2014, 65 (03) : 667 - 668
  • [10] Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
    Mejean, Arnaud
    Ravaud, Alain
    Thezenas, Simon
    Chevreau, Christine
    Bensalah, Karim
    Geoffrois, Lionnel
    Thiery-Vuillemin, Antoine
    Cormier, Luc
    Lang, Herve
    Guy, Laurent
    Gravis, Gwenaelle
    Rolland, Frederic
    Linassier, Claude
    Lechevallier, Eric
    Oudard, Stephane
    Laguerre, Brigitte
    Gross-Goupil, Marine
    Bernhard, Jean Christophe
    Colas, Sandra
    Albiges, Laurence
    Lebret, Thierry
    Treluyer, Jean-Marc
    Timsit, Marc-Olivier
    Escudier, Bernard
    EUROPEAN UROLOGY, 2021, 80 (04) : 417 - 424